Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population.
Tchetche D, Dumonteil N, Sauguet A, Descoutures F, Luz A, Garcia O, Soula P, Gabiache Y, Fournial G, Marcheix B, Carrie D, Fajadet J. Tchetche D, et al. Among authors: fajadet j. EuroIntervention. 2010 Jan;5(6):659-65. doi: 10.4244/eijv5i6a109. EuroIntervention. 2010. PMID: 20142215 Clinical Trial.
Twelve month clinical and angiographic outcome after stenting of unprotected left main coronary artery stenosis with paclitaxel-eluting stents--results of the multicentre FRIEND registry.
Carrié D, Eltchaninoff H, Lefèvre T, Silvestri M, Levy G, Maupas E, Brunel P, Fajadet J, Le Breton H, Gilard M, Blanchard D, Glatt B; FRIEND. Carrié D, et al. Among authors: fajadet j. EuroIntervention. 2009 Jan;4(4):449-56. doi: 10.4244/eijv4i4a78. EuroIntervention. 2009. PMID: 19284066
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II.
Vaina S, Voudris V, Morice MC, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Macours N, Stoll HP, Cokkinos DV, Stefanadis C, Serruys PW; ARTSII. Vaina S, et al. Among authors: fajadet j. EuroIntervention. 2009 Jan;4(4):492-501. doi: 10.4244/eijv4i4a84. EuroIntervention. 2009. PMID: 19284072 Clinical Trial.
Radial approach for percutaneous coronary intervention.
Luz A, Hughes C, Fajadet J. Luz A, et al. Among authors: fajadet j. EuroIntervention. 2009 Nov;5(5):633-5. doi: 10.4244/eijv5i5a101. EuroIntervention. 2009. PMID: 20142186 Review. No abstract available.
Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study.
Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Baldus S, Hauptmann KE, Suttorp MJ, Drzewiecki J, Pieper M, Schultheiss HP, Mauri L. Fajadet J, et al. EuroIntervention. 2010 Nov;6(5):562-7. doi: 10.4244/EIJV6I5A95. EuroIntervention. 2010. PMID: 21044908
The Nile concept.
Fajadet J. Fajadet J. EuroIntervention. 2010 Dec;6 Suppl J:J135-8. doi: 10.4244/EIJV6SUPJA22. EuroIntervention. 2010. PMID: 21930478 No abstract available.
269 results